Application
Western blot analysis of extracts from COLO cells, using NRIP3 Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | NRIP3 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to NRIP3 |
| Immunogen | The antiserum was produced against synthesized peptide derived from human NRIP3. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAWB |
| ELISA: 1:20000Optimal dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | Sarcoma antigen NYSAR105 Sarcoma antigen NY-SAR-105 Nuclear receptor-interacting protein 3 Nuclear receptorinteracting protein3 NRIP3 Nuclear receptorinteracting protein 3 Sarcoma antigen NY SAR 105 |
|---|---|
| Target | NRIP3 |
| Molecular Weight(MW) | 26 kDa (note) |
| Tissue Specificity | NRIP3 Antibody detects endogenous levels of total NRIP3 protein. |
Application
Western blot analysis of extracts from COLO cells, using NRIP3 Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | ELISA: 1:20000Optimal dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
